JYNT250117C12500
- 0.05
- 0.000.00%
The Joint Newsroom
Crystal Clinic Orthopaedic Center Earns National Recognition as Top 100 Hospital From CareChex
When Should You Buy The Joint Corp. (NASDAQ:JYNT)?
StaffDNA; LiquidAgents CEO Sheldon Arora Named to the 2025 SIA Staffing 100 North America List
The Joint Corp Shares Are Trading Higher After the Company Announced a Year-over-year Increase in Patient Visits.
Craig-Hallum Maintains The Joint(JYNT.US) With Hold Rating
Lake Street Maintains The Joint(JYNT.US) With Buy Rating, Maintains Target Price $20
The Joint Corp Performed 14.7M Patient Visits In 2024, Compared To 13.6M In 2023
Express News | Joint Corp - Received Lois to Refranchise Majority of Corporate Clinic Portfolio in Jan
Express News | Joint Corp: In H1, We Will Initiate Thoughtful Price Increases
VirtuAlly Awarded Accreditation for Telehealth Services From The Joint Commission
EDCare Introduces Residential Eating Disorder Program in Denver
Settlement of the Joint Procedure and Delisting of the Unieuro Shares From the Euronext Star Milan
The Joint Chiropractic Makes List of Top 40 Smartest-Growing Franchises
Brightside Health Earns The Joint Commission's Gold Seal of Approval
Soleo Health Unveils Ambulatory Infusion Suite in Denver
Fnac Darty: Final Results and Terms of Settlement of the Joint Procedure
With 46% Stake, The Joint Corp. (NASDAQ:JYNT) Seems to Have Captured Institutional Investors' Interest
Preliminary Results of the Joint Procedure
Earnings Call Summary | The Joint(JYNT.US) Q3 2024 Earnings Conference
The Joint Commission and Kaiser Permanente Announce Winner of 2024 Bernard J. Tyson National Award for Excellence in Pursuit of Healthcare Equity